Gérard J-P, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(28):4620–5. https://doi.org/10.1200/JCO.2006.06.7629.
2.Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40. https://doi.org/10.1056/NEJMoa040694.
CAS Article PubMed Google Scholar
3.Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(16):1926–33. https://doi.org/10.1200/JCO.2011.40.1836.
4.Ngan SY, Burmeister B, Fisher RJ, et al. Randomized trial of short course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(31):3827–33. https://doi.org/10.1200/JCO.2012.42.9597.
5.Erlandsson J, Holm T, Pettersson D, et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol. 2017;18(3):336–46. https://doi.org/10.1016/S1470-2045(17)30086-4.
6.Colorectal Cancer - Statistics. Cancer.Net. Published June 25, 2012. Accessed May 31, 2021. https://www.cancer.net/cancer-types/colorectal-cancer/statistics
7.Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19–23.
8.Ryan R, Gibbons D, Hyland JMP, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141–6. https://doi.org/10.1111/j.1365-2559.2005.02176.x.
CAS Article PubMed Google Scholar
9.Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer. 1994;73(11):2680–6. https://doi.org/10.1002/1097-0142(19940601)73:11%3c2680::aid-cncr2820731105%3e3.0.co;2-c.
CAS Article PubMed Google Scholar
10.Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46. https://doi.org/10.1056/NEJMoa010580.
CAS Article PubMed Google Scholar
11.Janjan NA, Crane C, Feig BW, et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol. 2001;24(2):107–12.
12.Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(15):1770–6. https://doi.org/10.1200/JCO.2011.39.7901.
13.Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–717; discussion 717–718.
14.Ellis CT, Samuel CA, Stitzenberg KB. National trends in nonoperative management of rectal adenocarcinoma. J Clin Oncol. Published online March 28, 2016:JCO642066. https://doi.org/10.1200/JCO.2015.64.2066
15.Yang TJ, Goodman KA. Predicting complete response: is there a role for non-operative management of rectal cancer? J Gastrointest Oncol. 2015;6(2):241–6. https://doi.org/10.3978/j.issn.2078-6891.2014.110.
Article PubMed PubMed Central Google Scholar
16.Pham TT, Liney GP, Wong K, Barton MB. Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer. Br J Radiol. 2017;90(1072):20151078. https://doi.org/10.1259/bjr.20151078.
Article PubMed PubMed Central Google Scholar
17.Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655. https://doi.org/10.1259/bjr.20180655.
Article PubMed PubMed Central Google Scholar
18.Fusco R, Petrillo M, Granata V, et al. Magnetic resonance imaging evaluation in neoadjuvant therapy of locally advanced rectal cancer: a systematic review. Radiol Oncol. 2017;51(3):252–62. https://doi.org/10.1515/raon-2017-0032.
Article PubMed PubMed Central Google Scholar
19.Park SH, Cho SH, Choi SH, et al. MRI assessment of complete response to preoperative chemoradiation therapy for rectal cancer: 2020 guide for practice from the Korean Society of Abdominal Radiology. Korean J Radiol. 2020;21(7):812–28. https://doi.org/10.3348/kjr.2020.0483.
Article PubMed PubMed Central Google Scholar
20.Malayeri AA, El Khouli RH, Zaheer A, et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiogr Rev Publ Radiol Soc N Am Inc. 2011;31(6):1773–91. https://doi.org/10.1148/rg.316115515.
21.Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A. 2005;102(15):5524–9. https://doi.org/10.1073/pnas.0501532102.
CAS Article PubMed PubMed Central Google Scholar
22.Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer Oxf Engl 1990. 2009;45(2):228–247. https://doi.org/10.1016/j.ejca.2008.10.026
23.Lee MA, Cho SH, Seo AN, et al. Modified 3-point MRI-based tumor regression grade incorporating DWI for locally advanced rectal cancer. Am J Roentgenol. 2017;209(6):1247–55. https://doi.org/10.2214/AJR.16.17242.
24.Yoen H, Park HE, Kim SH, et al. Prognostic value of tumor regression grade on MR in rectal cancer: a large-scale, single-center experience. Korean J Radiol. 2020;21(9):1065–76. https://doi.org/10.3348/kjr.2019.0797.
Article PubMed PubMed Central Google Scholar
25.Chandramohan A, Siddiqi UM, Mittal R, et al. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open. 2020;7. https://doi.org/10.1016/j.ejro.2020.100223
26.van Heeswijk MM, Lambregts DMJ, Palm WM, et al. DWI for assessment of rectal cancer nodes after chemoradiotherapy: is the absence of nodes at DWI proof of a negative nodal status? Am J Roentgenol. 2016;208(3):W79–84. https://doi.org/10.2214/AJR.16.17117.
27.Gollub MJ, Das JP, Bates DDB, et al. Rectal cancer with complete endoscopic response after neoadjuvant therapy: what is the meaning of a positive MRI? Eur Radiol. Published online January 15, 2021. https://doi.org/10.1007/s00330-020-07657-0
28.Shaverdian N, Yang Y, Hu P, et al. Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer. Br J Radiol. 2017;90(1071):20160739. https://doi.org/10.1259/bjr.20160739.
Article PubMed PubMed Central Google Scholar
29.De Felice F, Magnante AL, Musio D, et al. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2017;43(7):1324–9. https://doi.org/10.1016/j.ejso.2017.03.010.
30.Palmisano A, Di Chiara A, Esposito A, et al. MRI prediction of pathological response in locally advanced rectal cancer: when apparent diffusion coefficient radiomics meets conventional volumetry. Clin Radiol. 2020;75(10):798.e1-798.e11. https://doi.org/10.1016/j.crad.2020.06.023.
31.Yang L, Qiu M, Xia C, et al. Value of high-resolution DWI in combination with texture analysis for the evaluation of tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer. AJR Am J Roentgenol. Published online March 12, 2019:1–8. https://doi.org/10.2214/AJR.18.20689
32.Bassaneze T, Gonçalves JE, Faria JF, Palma RT, Waisberg J. Quantitative aspects of diffusion-weighted magnetic resonance imaging in rectal cancer response to neoadjuvant therapy. Radiol Oncol. 2017;51(3):270–6. https://doi.org/10.1515/raon-2017-0025.
CAS Article PubMed PubMed Central Google Scholar
33.Tarallo N, Angeretti MG, Bracchi E, et al. Magnetic resonance imaging in locally advanced rectal cancer: quantitative evaluation of the complete response to neoadjuvant therapy. Pol J Radiol. 2018;83:e600–9. https://doi.org/10.5114/pjr.2018.81156.
Article PubMed PubMed Central Google Scholar
34.Crimì F, Stramare R, Spolverato G, et al. T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy. Tech Coloproctol. 2021;25(5):569–77. https://doi.org/10.1007/s10151-021-02440-9.
Article PubMed PubMed Central Google Scholar
35.Bulens P, Couwenberg A, Haustermans K, et al. Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2018;126(3):437–42. https://doi.org/10.1016/j.radonc.2018.01.008.
36.Joye I, Debucquoy A, Deroose CM, et al. Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2017;124(1):104–9. https://doi.org/10.1016/j.radonc.2017.06.013.
37.Schurink NW, Min LA, Berbee M, et al. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Eur Radiol. 2020;30(5):2945–54. https://doi.org/10.1007/s00330-019-06638-2.
38.•• Tang Z, Zhang X-Y, Liu Z, et al. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2019;132:100–8. https://doi.org/10.1016/j.radonc.2018.11.007. A large patient cohort study (152 training and 70 validation) investigating the usage of radiomics and clinical characteristics for LARC down-staging prediction.
39.Bulens P, Couwenberg A, Intven M, et al. Predicting the tumor response to chemoradiotherapy for rectal cancer: model development and external validation using MRI radiomics. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2020;142:246–52. https://doi.org/10.1016/j.radonc.2019.07.033.
40.Chen F, Ma X, Li S, et al. MRI-based radiomics of rectal cancer: assessment of the local recurrence at the site of anastomosis. Acad Radiol. Published online November 5, 2020. https://doi.org/10.1016/j.acra.2020.09.024
41.Wan L, Peng W, Zou S, et al. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Acad Radiol. Published online November 11, 2020. https://doi.org/10.1016/j.acra.2020.10.026
42.van Griethuysen JJM, Lambregts DMJ, Trebeschi S, et al. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer. Abdom Radiol. 2020;45(3):632–43. https://doi.org/10.1007/s00261-019-02321-8.
43.Nardone V, Reginelli A, Scala F, et al. Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation. Gastroenterol Res Pract. 2019;2019:e8505798. https://doi.org/10.1155/2019/8505798.
44.Fu J, Zhong X, Li N, et al. Deep learning-based radiomic features for improving neoadjuvant chemoradiation response prediction in locally advanced rectal cancer. Phys Med Biol. 2020;65(7):075001. https://doi.org/10.1088/1361-6560/ab7970.
45.Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2015;278(2):563–77. https://doi.org/10.1148/radiol.2015151169.
46.Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505. https://doi.org/10.1148/radiology.168.2.3393671.
留言 (0)